Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial (Q38785900)

6 September 2017

title

Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial (English)

1 reference

6 September 2017

1 reference

Amirhossein Sahebkar

1 reference

6 September 2017

Yunes Panahi

1 reference

6 September 2017

Nahid Khalili

1 reference

6 September 2017

Ebrahim Sahebi

1 reference

6 September 2017

Soha Namazi

1 reference

6 September 2017

Maryam Saberi Karimian

1 reference

6 September 2017

Muhammed Majeed

1 reference

6 September 2017

publication date

7 December 2016

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

25-31

1 reference

Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS)

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Antioxidants and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Antioxidant anti-inflammatory treatment in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Diabetes and atherosclerosis: is there a role for hyperglycemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin: An Effective Inhibitor of Interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Oxidative Stress and Diabetic Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin as a natural regulator of monocyte chemoattractant protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Molecular targets of curcumin for cancer therapy: an updated review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Multiple biological activities of curcumin: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin: A new candidate for melanoma therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin as a MicroRNA Regulator in Cancer: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Dietary antioxidant intake and risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Glucolipotoxicity: fuel excess and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Diabetes Treatment — Bridging the Divide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Anti-tumour and antioxidant activity of natural curcuminoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Molecular mechanisms for curcumin benefits against ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

The impact of glucose-lowering therapy on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Germinated Pigeon Pea (Cajanus cajan): a novel diet for lowering oxidative stress and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

21 January 2018

The targets of curcumin.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-016-0301-4

Curcuminoids for the management of hypertriglyceridaemia

21 January 2018

1 reference

12 December 2020

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

12 December 2020

Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial

1 reference

12 December 2020

Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes

1 reference

12 December 2020

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

12 December 2020

Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial

1 reference

12 December 2020

Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial

1 reference

12 December 2020

Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models.

1 reference

12 December 2020

10.1007/S10787-016-0301-4

Identifiers

DOI

1 reference

6 September 2017

1 reference